Full-Thickness Resection With Myocutaneous Flap Reconstruction for Locally Recurrent Breast Cancer Godehard Friedel, MD, FETCS, Thomas Kuipers, MD, Jürgen.

Slides:

Advertisements

Similar presentations

Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease Srikrishna Sirivella, MD, Isaac Gielchinsky,

Advertisements

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients Chi-Fu Jeffrey Yang, MD, Nicholas R. Mayne,

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes Meng S. Shao, MD, Andrew T. Wong, MD,

Bharat Pancholy, MD, Jai Raman, MD, PhD The Annals of Thoracic Surgery

Coronary Artery Bypass for Heart Failure in Ischemic Cardiomyopathy: 17-Year Follow- Up Marco Pocar, MD, PhD, Andrea Moneta, MD, Adalberto Grossi, MD,

Thomas J. Birdas, MD, Richard P. M

Constantin Stefanidis, MD, Albert M

Bilateral Double Free-Flaps for Reconstruction of Extensive Chest Wall Defect Emre Gazyakan, MD, Holger Engel, MD, Marcus Lehnhardt, MD, PhD, Michael.

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Pacemaker Therapy After Tricuspid Valve Operations: Implications on Mortality, Morbidity, and Quality of Life Janne J. Jokinen, MD, Anu K. Turpeinen,

Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.

Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery Farkas B. Vánky, MD, PhD, Erik.

Long-Term Outcome of Patients With Complete Atrioventricular Septal Defect Combined With the Tetralogy of Fallot: Staged Repair Is Not Inferior to Primary Repair

Salvage Resections for Recurrent or Persistent Cancer of the Proximal Esophagus After Chemoradiotherapy Colin Schieman, MD, Dennis A. Wigle, MD, PhD,

Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma Giulio Melloni, MD, Claudio.

Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes Julie E. Bauman, MD, Michael.

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Forequarter Amputation Combined With Chest Wall Resection: A Single-Center Experience Patrick Nierlich, MD, Philipp Funovics, MD, Martin Dominkus, MD,

Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Robert E. Freundlich, MD, MS, Michael D. Maile, MD, MS, Mark M

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Jong Ho Cho, MD, Masatsugu Hamaji, MD, Mark S. Allen, MD, Stephen D

Risk Factors for Lymph Node Metastases and Prognosticators of Survival in Patients Undergoing Pulmonary Metastasectomy for Colorectal Cancer Servet Bölükbas,

Linetta B. Koppert, MD, PhD, Albertus N. van Geel, MD, PhD, Titia E

Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.

Trimodal Therapy for Histologically Proven N2/3 Non–Small Cell Lung Cancer: Mid-Term Results and Indicators for Survival Volker Steger, MD, Thorsten.

Outcome of Esophagectomy for Cancer in Elderly Patients

Survival of Patients With or Without Symptoms Undergoing Potentially Curative Resections for Primary Lung Cancer Andrea R.G. Sheel, BS (Hons), MBChB,

Pulmonary Resection in the Treatment of Multidrug-Resistant Tuberculosis: A Retrospective Study of 56 Cases Haifeng Wang, MM, Hongsheng Lin, MM, Gening.

Factors Affecting Survival After Mitral Valve Replacement in Patients With Prosthesis– Patient Mismatch Abdulhameed Aziz, MD, Jennifer S. Lawton, MD,

Susanne Lison, MD, Michael Spannagl, MD, PhD, Wulf Dietrich, MD, PhD

Long-Term Outcomes After Surgical Resection of Pulmonary Metastases From Colorectal Cancer Hisashi Suzuki, MD, PhD, Moriyuki Kiyoshima, MD, Miyuki Kitahara,

Chordae Replacement Versus Resection for Repair of Isolated Posterior Mitral Leaflet Prolapse: À Ègalité Joerg Seeburger, MD, Volkmar Falk, MD, PhD,

Thomas J. Birdas, MD, Richard P. M

Dylan R. Nieman, MD, PhD, Christian G. Peyre, MD, Thomas J

Radical Lymph Node Dissection in Primary Esophagectomy for Esophageal Squamous Cell Carcinoma Chen-Sung Lin, MD, PhD, Chih-Tao Cheng, MD, DrPH, Chao-Yu.

Use of Amiodarone After Major Lung Resection

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Robert R. McMillan, MD, MPH, Camelia S. Sima, MD, MS, Nicole H

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Interaction of Donor and Recipient Age: Do Older Heart Transplant Recipients Require Younger Hearts? Malini Daniel, MD, Carol Chen, MD, Jennifer Chung,

Primary Cardiac Sarcoma

Radiofrequency Ablation for the Treatment of Pulmonary Metastases

Sublobar Resection Provides an Equivalent Survival After Lobectomy in Elderly Patients With Early Lung Cancer Jiro Okami, MD, PhD, Yuri Ito, PhD, Masahiko.

Radiofrequency Ablation for Stage I Non-Small Cell Lung Cancer: Management of Locoregional Recurrence Michael Lanuti, MD, Amita Sharma, MD, Henning Willers,

Douglas E. Paull, MD, Glenda M. Updyke, PA-C, Michael A

Surgical Treatment of Aortic Prosthetic Valve Endocarditis: A 20-Year Single-Center Experience Sossio Perrotta, MD, Anders Jeppsson, MD, PhD, Victoria.

Pulmonary Resection for Metastases from Colorectal Cancer

Arman Kilic, BS, Matthew J. Schuchert, MD, Brian L

Margin Distance Does Not Influence Recurrence and Survival After Wedge Resection for Lung Cancer Giulio Maurizi, MD, Antonio D’Andrilli, MD, Anna Maria.

Predictors of Recurrent Pulmonary Metastases and Survival After Pulmonary Metastasectomy for Colorectal Cancer Shanda H. Blackmon, MD, MPH, Elizabeth.

Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer Pamela Samson, MD,

Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study Hans Rostad, MD, PhD, Trond-Eirik Strand, MD, Anne Naalsund, MD, Jarle Norstein,

Prolonged Intensive Care Unit Stay in Cardiac Surgery: Risk Factors and Long-Term- Survival Ortrud Vargas Hein, MD, Jürgen Birnbaum, MD, Klaus Wernecke,

Modern Outcome and Risk Analysis of Surgically Resected Occult N2 Non-Small Cell Lung Cancer Hyun Jin Cho, MD, Sung Ryong Kim, MD, Hyeong Ryul Kim, MD,

Cardiac Myxomas: A 50-Year Experience With Resection and Analysis of Risk Factors for Recurrence Ishan K. Shah, MD, Joseph A. Dearani, MD, Richard C.

Propensity Score Analysis Comparing Videothoracoscopic Lobectomy With Thoracotomy: A French Nationwide Study Pierre-Benoit Pagès, MD, PhD, Jean-Philippe.

Effect of Formalin Fixation on Tumor Size Determination in Stage I Non-Small Cell Lung Cancer Po-Kuei Hsu, MD, Hsu-Chih Huang, MD, Chih-Cheng Hsieh,

Who Gains Most? A 10-Year Experience With 611 Thoracoscopic Talc Pleurodeses Volker Steger, MD, Ute Mika, Heikki Toomes, MD, Tobias Walker, MD, Corinna.

Lobectomy for Lung Cancer at Veterans Administration Medical Center Versus Academic Medical Center Travis Geraci, MD, Vanessa Baratta, MD, John Young,

Increased Rehospitalization Rate After Coronary Bypass Operation for Acute Coronary Syndrome: A Prospective Study in 200 Patients Staffan Bjessmo, MD,

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

Slide Tracheoplasty in Infants and Children: Risk Factors for Prolonged Postoperative Ventilatory Support Peter B. Manning, MD, Michael J. Rutter, MD,

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Esophagectomy for T1 Esophageal Cancer: Outcomes in 100 Patients and Implications for Endoscopic Therapy Arjun Pennathur, MD, Andrew Farkas, BA, Alyssa.

Presentation transcript:

Full-Thickness Resection With Myocutaneous Flap Reconstruction for Locally Recurrent Breast Cancer Godehard Friedel, MD, FETCS, Thomas Kuipers, MD, Jürgen Dippon, PhD, Fawaz Al-Kammash, MD, Thorsten Walles, MD, Thomas Kyriss, MD, Stefanie Veit, MD, Michael Greulich, MD, Volker Steger, MD The Annals of Thoracic Surgery Volume 85, Issue 6, Pages 1894-1900 (June 2008) DOI: 10.1016/j.athoracsur.2008.02.012 Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Cumulative survival concerning bone infiltration (dashed line) vs no bone infiltration (solid line) of the chest wall. (Dotted lines represent 95% confidence intervals; log-rank comparison of both survival curves, p = 0.0024).Patients at Risk0 m60 m120 m180 m240 mNo bone infiltration3011633Bone infiltration25422... The Annals of Thoracic Surgery 2008 85, 1894-1900DOI: (10.1016/j.athoracsur.2008.02.012) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Cumulative survival concerning disease free interval (DFI) exceeding 48 months (solid line) vs DFI of 48 months or less (dashed line). (The dotted lines represent 95% confidence intervals; log-rank comparison of both survival curves, p = 0.0024).Patients at Risk0 m60 m120 m180 m240 mDFI > 48 m4712555DFI ≤ 48 m16552... The Annals of Thoracic Surgery 2008 85, 1894-1900DOI: (10.1016/j.athoracsur.2008.02.012) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Cumulative survival for aged 45 years or younger (solid line) or older than 45 years (dashed line) at the time of primary treatment. (The dotted lines represent 95% confidence intervals; log-rank comparison of survival curves, p = 0.0024).Patients at Risk0 m60 m120 m180 m240 mAge ≤ 45 y2411544Age > 45 y3943...... The Annals of Thoracic Surgery 2008 85, 1894-1900DOI: (10.1016/j.athoracsur.2008.02.012) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions